Antimicrobial resistance: calculating the cost

A Westminster Health Forum policy conference recently highlighted the economic impact of antimicrobial resistance. High on the agenda was the question: how can we incentivise the development of new antimicrobials? Louise Frampton reports.

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.